“This publication validates our belief that precision medicine should be measured, not marketed,” said Katy Whalen, ...

Teeth function not only because of the hard enamel on the surface, but also because they have roots that anchor them firmly ...

UCSD and the Department of Veterans Affairs Collaboration CARLSBAD, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — AVACEN Medical announced today that Dr. Francisco Cidral, ND, PhD’s ...

Australian learning platform expands to U.S. classrooms with debut at NABT 2025 in St. Louis. ST. LOUIS, MO / ACCESS Newswire / October 28, 2025 / BioBrain, the innovative digital learning platform ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival LA JOLLA, CA, Sept. 11, 2025 ...

Phase 2 of AP-101 in sporadic ALS and mutant SOD1-ALS met its primary safety and tolerability endpoint Clinically meaningful changes in outcome measures and stabilization of biomarkers were observed ...

OpenAI is rolling out a new Study Mode the company says is designed to give students a better understanding of complex topics. Like Claude's Learning Mode, which Anthropic introduced in April, Study ...

The last time I spoke about Tourmaline Bio (TRML) it was with respect to a Seeking Alpha article entitled "Tourmaline Bio: Looking To Go Beyond FcRn Inhibition With IL-6 Targeting." In this article, I ...

HENDERSON, Nev.--(BUSINESS WIRE)-- Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company dedicated to developing novel dual-pathway antibodies ...

Belite Bio's lead drug, Tinlarebant, shows promise in rare eye diseases, but pivotal data and regulatory approval remain at least 18 months away in my view. The DRAGON study's interim analysis is ...